RZL-012 is an injectable treatment for focal fat reduction that is currently progressing toward Phase 3 trials.

Antares Vision Group, a leader in the digitalization and traceability of products and supply chains for companies and ...

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has launched the AAW Automated ...

The two companies will scale production for a novel recombinant version of alpha-1 antitrypsin targeting lung diseases.